好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Association Between Hyperlipidemia of the US population and Cerebrovascular Diseases (CVD) Mortality from 1999 to 2020.
General Neurology
P8 - Poster Session 8 (8:00 AM-9:00 AM)
11-010
To determine the mortality trends and disparities in hyperlipidemia-related cerebrovascular diseases (CVD) among older adults in the United States.
Hyperlipidemia is a modifiable risk factor, affecting approximately 60-70% individuals with CVD, yet the trends and disparities in hyperlipidemia-related CVD remain overlooked.

Using the CDC WONDER multiple cause of death database, hyperlipidemia-related CVD mortality among older adults (65+ years) was examined from 1999-2020. Age-Adjusted Mortality Rates (AAMRs) per 100,000 individuals were calculated. Annual Percentage Change (APC) and trends were analyzed across demographic (gender, race/ethnicity) and regional groups using Joinpoint regression.


Between 1999 and 2020, 123,318 older adults suffered from hyperlipidemia-related CVD deaths in the US. Overall, The AAMR for mortality increased from 5.27 in 1999 and 20.9 in 2020, ascending from 1999 to 2004 (APC: 14.7 [12.3 to 18.6]). Following  a slower rise from 2004 to 2010 (APC: 5.7% [4.1 to 7.6]), the rates stabilized till 2018, with a significant rise from 2018 to 2020 (APC: 13.9 [9.9 to 16.8]) with an average annual percentage decrease of 6.6% (6.3 to 7.1). Males showed higher AAMR than females (14.45 vs 12.63). Non-Hispanic (NH) Blacks had the highest AAMR (14.44), followed by NH Whites (13.49), NH Asians (12.99), and Hispanics (10.78). Regionally, West had the highest AAMR (15.7) and Northeast the lowest (11.4). Additionally, non-metropolitan surpassed metropolitan areas, Vermont showing the highest AAMR (34.98) and Nevada the lowest (6.46).



These findings highlight significant differences in hyperlipidemia-related CVD deaths among older adults from 1999 to 2020, with males, NH Blacks, the western region and non-metropolitan areas being the most affected. This underscores the critical need to combat stroke mortality associated with hyperlipidemia by implementing targeted interventions, especially among high-risk groups.


Authors/Disclosures
Aidan Keaveny
PRESENTER
Mr. Keaveny has nothing to disclose.
Tabia Shujaat, MBBS Dr. Shujaat has nothing to disclose.
FNU Kalpina, MBBS Dr. Ramesh has nothing to disclose.
Javeria Javeid Mrs. Javeid has nothing to disclose.
Dinesh Kumar Dr. Kumar has nothing to disclose.
Madelyn N. Ross Ms. Ross has nothing to disclose.
Syed H. Inam, MD Dr. Inam has nothing to disclose.